Legal Representation
Attorney
Rodney L. Skoglund
USPTO Deadlines
Next Deadline
2067 days remaining
Section 8 Declaration Due (Supplemental Register) (Based on registration date 20250923)
Due Date
September 23, 2031
Grace Period Ends
March 23, 2032
Additional deadlines exist. Contact your attorney for complete deadline information.
Application History
15 events| Date | Code | Type | Description | Documents |
|---|---|---|---|---|
| Sep 23, 2025 | NRCS | E | NOTICE OF REGISTRATION CONFIRMATION EMAILED | Loading... |
| Sep 23, 2025 | R.SR | A | REGISTERED-SUPPLEMENTAL REGISTER | Loading... |
| Aug 27, 2025 | CNTA | O | APPROVED FOR REGISTRATION SUPPLEMENTAL REGISTER | Loading... |
| Aug 27, 2025 | IUAA | P | USE AMENDMENT ACCEPTED | Loading... |
| Aug 26, 2025 | TROA | I | TEAS RESPONSE TO OFFICE ACTION RECEIVED | Loading... |
| Aug 22, 2025 | AUPC | I | AMENDMENT TO USE PROCESSING COMPLETE | Loading... |
| Aug 22, 2025 | IUAF | S | USE AMENDMENT FILED | Loading... |
| Aug 22, 2025 | EAAU | I | TEAS AMENDMENT OF USE RECEIVED | Loading... |
| Aug 4, 2025 | GNRN | O | NOTIFICATION OF NON-FINAL ACTION E-MAILED | Loading... |
| Aug 4, 2025 | GNRT | F | NON-FINAL ACTION E-MAILED | Loading... |
| Aug 4, 2025 | CNRT | R | NON-FINAL ACTION WRITTEN | Loading... |
| Aug 4, 2025 | DOCK | D | ASSIGNED TO EXAMINER | Loading... |
| Feb 28, 2025 | MAFR | O | APPLICATION FILING RECEIPT MAILED | Loading... |
| Feb 28, 2025 | NWOS | I | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED | Loading... |
| Feb 28, 2025 | NWAP | I | NEW APPLICATION ENTERED | Loading... |
Detailed Classifications
Class 005
Oral vaccine preparations; Adjuvants for use with vaccines; Adjuvants for medical purposes; Human vaccine preparations; Vaccine adjuvants; Vaccine preparations; Pharmaceutical preparations for the treatment of immune system related diseases and disorders; Pharmaceutical products for the prevention and treatment of cancer; Drug delivery agents in the form of tablets that provide controlled release of the active ingredients for a wide variety of pharmaceuticals; Drug delivery agents in the form of powders that provide controlled release of the active ingredients for a wide variety of pharmaceuticals; Drug delivery agents in the form of capsules that provide controlled release of the active ingredients for a wide variety of pharmaceuticals; Pharmaceutical preparations for the prevention and treatment of ocular disorders or diseases, bacteria-based diseases or disorders, autoimmune diseases or disorders, kidney diseases or disorders, and diabetes; Plant extracts, other than essential oils, for pharmaceutical purposes; Pharmaceutical preparations for the treatment of autoimmune diseases; Pharmaceutical products for the treatment of viral diseases
First Use Anywhere:
Nov 22, 2023
First Use in Commerce:
Nov 22, 2023
Additional Information
Pseudo Mark
QS ORAL
Pseudo Mark
QSORAL
Pseudo Mark
QUILLAJA SAPONARIA-ORAL
Pseudo Mark
QUILLAJA SAPONARIA ORAL
Classification
International Classes
005